Bahrain approves Sinopharm vaccine for children aged 3-11

The Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11

  
Boxes of COVID-19 vaccines are seen at a packaging workshop inside the Beijing Institute of Biological Products of Sinopharm's China National Biotec Group (CNBG), during a government-organised visit to the company’s production line in Beijing, China February 26, 2021. Image used for illustrative purpose.

Boxes of COVID-19 vaccines are seen at a packaging workshop inside the Beijing Institute of Biological Products of Sinopharm's China National Biotec Group (CNBG), during a government-organised visit to the company’s production line in Beijing, China February 26, 2021. Image used for illustrative purpose.

REUTERS/Tingshu Wang

DUBAI- Bahrain has approved the Sinopharm COVID-19 vaccine for children aged between 3 and 11 years from October 27, the state media office said on Tuesday.

The Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11, it also said.

(Reporting by Alexander Cornwell; Editing by Andrew Cawthorne) ((Alexander.Cornwell@thomsonreuters.com;))


More From Health